ISSN: 2332-0877

Revista de terapia y enfermedades infecciosas

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Estimation of Anti-Tubercular Drug Resistance in Relapse TB Patients in Rims Hospital, Srikakulam

Harikrishna Allu, Sowmyasree Mudakala, Madhavi Singupuram and Udaya Sri Kaviti

Relapse TB means the patient had a TB he was previously been treated for TB. Most of such patients had Multi-Drug resistance for first line TB treatment. Method and Materials: These studies were conducted based on observational study in this study we utilized quantitative method to find an effected population. Result: we gathered total 150 population in the period of six months in that 63 individuals were sent for CBNAT test (Rifampicin Resistant test) out of that 40 samples were got a positive results to Rifampicin Resistant, in that male 36 (57.1%) were higher than females 4(6.3%) and adults 31(49.2%) were more than the other age groups, based on the location Srikakulam zone were higher than the other zones. Conclusion: Relapse TB and Multidrug resistant caused due to failure of TB treatment, infected with drug resistant mycobacteria.